FDA
label_change
· 2006-08-28
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin from Prasco Laboratories, resulting in labeling and post-a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)